| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |